Featuring: Robert F Kushner, MD
The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern's Robert Kushner, MD, led this study published in the New England Journal of Medicine and shares the results.
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
This podcast was originally release via the Feinberg School of Medicine News Center in February 2021.
Robert Kushner, MD is Professor of Medicine in the Division of Endocrinology and Professor of Medical Education.
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.